Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. CRWV
8. CME
9. ADBE
10. HUMA

Go back to Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
Asianada, Inc. (NASDAQ: ASND) Delayed: 215.60 +5.81 (2.77%)
Previous Close $209.79    52 Week High $21.79 
Open $209.72    52 Week Low $11.92 
Day High $219.28    P/E N/A 
Day Low $208.00    EPS $-0.07 
Volume 694,871       

REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 55.29 +0.77 (1.41%)
Previous Close $54.52    52 Week High $3.48 
Open $55.17    52 Week Low $0.80 
Day High $55.40    P/E N/A 
Day Low $54.85    EPS $-1.54 
Volume 3,073,041